NovoMix 30 30%+70% (SC Injection)

3 ml flexpen: ৳ 1,005.00 (5's pack: ৳ 5,025.00)

Medicine Details

Category Details
Generic Biphasic insulin aspart
Company Novo nordisk pharma pvt ltd

Indications

  • Improve glycemic control in adults with type 1 diabetes mellitus
  • Improve glycemic control in children with type 1 diabetes mellitus
  • Improve glycemic control in adults with type 2 diabetes mellitus

Composition

  • Each ml suspension contains Insulin Aspart (rDNA) 100 units
  • Equaivalent to 3.5 mg as 30% soluble Insulin Aspart and 70% Insulin Aspart Protamine suspension

Pharmacology

  • Contains 30% soluble Insulin Aspart
  • Contains 70% Insulin Aspart Protamine crystals
  • Blood glucose lowering agent
  • Earlier onset and intermediate duration of action
  • Produced by recombinant DNA technology utilizing Saccharomyces cerevisiae (baker’s yeast)

Dosage

  • Subcutaneous injection
  • Use in pumps
  • Intravenous use
  • Dosage must be individualized

Administration

  • Use of insulin syringe
  • Proper mixing of insulin
  • Injection process
  • Pre-administration checklist

Interaction

  • Substances affecting glucose metabolism may require dose adjustment
  • Substances that may increase blood glucose lowering effect
  • Substances that may reduce blood glucose lowering effect
  • Close monitoring required

Contraindications

  • Contraindicated during episodes of hypoglycemia
  • Contraindicated in patients with hypersensitivity to Insulin Aspart or any of its excipients

Side Effects

  • Hypoglycemia
  • Lipodystrophy
  • Weight gain
  • Peripheral edema

Pregnancy & Lactation

  • Pregnancy category B
  • Careful monitoring of glucose control
  • Advice for female patients intending to become or who become pregnant
  • Unknown excretion in human milk
  • Need for insulin dose adjustments in lactating women

Precautions & Warnings

  • Blood glucose monitoring in all patients
  • Insulin regimen modification under medical supervision
  • Dose adjustment for renal or hepatic impairment

Use in Special Populations

  • Pediatric use not studied in certain age groups

Overdose Effects

  • May result in hypoglycemia
  • Treatment options for mild and severe hypoglycemia
  • Potential need for drug dosage, meal pattern, or exercise adjustments

Therapeutic Class

  • Combination Insulin

Storage Conditions

  • Refrigeration at 2°C to 8°C
  • Protection from freezing, heat, and light
  • Room temperature storage for insulin in use

Related Brands